‘Pharma Bro’ banned from industry in FTC victory

A federal judge ordered Martin Shkreli, known as “Pharma Bro,” to disgorge $64.6 million in net profits for violating antitrust laws to hike the price of life-saving medication....

Subscription required to view this article.

This content can only be accessed by FTCWatch subscribers. If you are an FTCWatch subscriber, please login to access this content

If you do not currently subscribe to FTCWatch please contact us for subscription information:
Email: customerservices@mlex.com

FTCWatch is delivered in the following formats: via email alert and online at mlexwatch.com/ftcwatch